Evidence map›Paper›PMID 37959750›Full record

ArticleMolecules (Basel, Switzerland)2023

Volatile Composition, Antimicrobial Activity, and In Vitro Innate Immunomodulatory Activity of

Noura S Dosoky, Liliya N Kirpotina, Igor A Schepetkin, Andrei I Khlebnikov, Brent L Lisonbee, Jeffrey L Black, Hillary Woolf, Trever L Thurgood, Brittany L Graf, Prabodh Satyal and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 21 citations in OpenAlex.

  1. Effect ofVeterinary and animal science · 2026
    Article
  2. Review
  3. Article
  4. Chemical Compositions ofPlants (Basel, Switzerland) · 2026
    Article
  5. Bioactivity ofMolecules (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Development ofBeilstein journal of nanotechnology · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Antimicrobial Activity ofPharmaceuticals (Basel, Switzerland) · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. The effect ofFrontiers in veterinary science · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Noura S DosokyEssential Oil Science, dōTERRA International, 1248 W 700 S, Pleasant Grove, UT 84062, USA.ORCID 0000-0002-4434-9146
Liliya N KirpotinaDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.
Igor A SchepetkinDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.
Andrei I KhlebnikovKizhner Research Center, Tomsk Polytechnic University, Tomsk 634050, Russia.ORCID 0000-0002-3022-4510
Brent L LisonbeeInnova Bio, Utah Valley University, 800 W University Pkwy, Orem, UT 84058, USA.
Jeffrey L BlackInnova Bio, Utah Valley University, 800 W University Pkwy, Orem, UT 84058, USA.ORCID 0009-0005-5181-7488
Hillary WoolfResearch and Development, dōTERRA International, 389 S 1300 W, Pleasant Grove, UT 84062, USA.ORCID 0000-0002-1802-8234
Trever L ThurgoodInnova Bio, Utah Valley University, 800 W University Pkwy, Orem, UT 84058, USA.
Brittany L GrafResearch and Development, dōTERRA International, 389 S 1300 W, Pleasant Grove, UT 84062, USA.
Prabodh SatyalEssential Oil Science, dōTERRA International, 1248 W 700 S, Pleasant Grove, UT 84062, USA.ORCID 0000-0002-2950-1074
Mark T QuinnDepartment of Microbiology and Cell Biology, Montana State University, Bozeman, MT 59717, USA.ORCID 0000-0001-8114-5073
Montana State University · USUtah Valley University · USEssential Research (United States) · USNational Research Tomsk State University · RU

Funding

Research Core (Developmental Research Project Program)P20GM103474 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI Jeffrey Good · 2012 to 2026
$60.0M
Tracking and Evaluation CoreU54GM115371 · NIGMS · MONTANA STATE UNIVERSITY - BOZEMAN · PI QUINN, MARK T, RASMUS, STACY M. · 2016 to 2020
$20.9M
NIGMS NIH HHS P20 GM103474NIGMS NIH HHS U54 GM115371NIH HHS GM103474NIH HHS GM115371
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Infective AgentsEchinaceaOils, VolatileBicyclic MonoterpenesCalciumCyclohexane MonoterpenesGas Chromatography-Mass SpectrometryHumansPolycyclic SesquiterpenesSesquiterpenes, GermacraneSteamalpha phellandrenealpha-pineneAnti-Infective Agentsbeta-pineneBicyclic MonoterpenesCalciumcaryophylleneCyclohexane Monoterpenesdelta-cadinenegermacrene DOils, VolatilePolycyclic SesquiterpenesSesquiterpenes, GermacraneSteamantimicrobial activitycalcium fluxchemotaxisEchinacea purpureaessential oilneutrophilpurple coneflower(+)-δ-cadinene

Identifiers

PMID37959750
PMCPMC10647913
OpenAlexW4388019695

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.